277 related articles for article (PubMed ID: 6091617)
1. A simplified immunofluorescence technique for antibody to varicella-zoster membrane antigen (FAMA).
Baba K; Yoshida M; Tawa A; Yabuuchi H; Maeda K; Takahashi M
Biken J; 1984 Mar; 27(1):23-9. PubMed ID: 6091617
[TBL] [Abstract][Full Text] [Related]
2. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
Sauerbrei A; Färber I; Brandstädt A; Schacke M; Wutzler P
J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test.
Gershon AA; Krugman S
Pediatrics; 1975 Dec; 56(6):1005-8. PubMed ID: 172853
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Chemicon SimulFluor direct fluorescent antibody staining with cell culture and shell vial direct immunoperoxidase staining for detection of herpes simplex virus and with cytospin direct immunofluorescence staining for detection of varicella-zoster virus.
Chan EL; Brandt K; Horsman GB
Clin Diagn Lab Immunol; 2001 Sep; 8(5):909-12. PubMed ID: 11527802
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis of virus-caused vesicular rashes by immunofluorescence on skin biopsies. I. Varicella, zoster and herpes simplex.
Olding-Stenkvist E; Grandien M
Scand J Infect Dis; 1976; 8(1):27-35. PubMed ID: 178050
[TBL] [Abstract][Full Text] [Related]
7. [Seroepidemiology of varicella-zoster virus infection measured by the fluorescent antibody to membrane antigen test].
Liu JJ; Wang ML; Gan L; Liao WJ; Chen J
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Apr; 30(4):371-5. PubMed ID: 19731531
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
[TBL] [Abstract][Full Text] [Related]
9. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections.
Gallo D; Schmidt NJ
J Clin Microbiol; 1981 Nov; 14(5):539-43. PubMed ID: 6273453
[TBL] [Abstract][Full Text] [Related]
10. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
[TBL] [Abstract][Full Text] [Related]
11. Antibody to varicella-zoster virus-induced membrane antigen: immunoperoxidase assay with air-dried target cells.
Haikin H; Leventon-Kriss S; Sarov I
J Infect Dis; 1979 Oct; 140(4):601-4. PubMed ID: 229177
[TBL] [Abstract][Full Text] [Related]
12. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
Sauerbrei A; Wutzler P
J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
[TBL] [Abstract][Full Text] [Related]
13. Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days.
Rolando L; Schneider WJ; Steinberg S; Low S; Stiles J; Gomez L; Gershon AA; Brown AE
Infect Control Hosp Epidemiol; 2010 Sep; 31(9):972-4. PubMed ID: 20666603
[No Abstract] [Full Text] [Related]
14. Indirect haemagglutination reaction with varicella-zoster virus antigen.
Trlifajová J; Pokorný J; Ryba M; Strízová V
J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
[No Abstract] [Full Text] [Related]
15. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
Chris Maple PA; Gray J; Brown K; Brown D
J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
[TBL] [Abstract][Full Text] [Related]
16. Enzyme immunoassay for antibodies to membrane associated antigen of varicella zoster virus.
Cox JC; Moloney MB; Herrington RW; Hampson AW; Hurrell JG
J Virol Methods; 1984 Feb; 8(1-2):137-45. PubMed ID: 6323506
[TBL] [Abstract][Full Text] [Related]
17. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
[TBL] [Abstract][Full Text] [Related]
18. A live varicella vaccine in a pediatric community.
Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of infections caused by varicella zoster virus].
Barraquer P; Rabella N; Labeaga R; Mercader M; Prats G
Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):277-8. PubMed ID: 9044653
[No Abstract] [Full Text] [Related]
20. Varicella-zoster virus IgM antibody fraction separated by minicolumn gel filtration in serodiagnosis of acute infection.
Kovác J; Zachar V; Reichel M; Necas S
Acta Virol; 1987 Jan; 31(1):19-24. PubMed ID: 2883853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
